At the European Society for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Jan Soupal discusses the latest data from the COMISAIR study.
Questions
1. Could you tell us a little about the aims and design of the COMISAIR trial? (0:05)
2. What were the major findings of this study? (2:22)
3. What were the limitations of this study and what future studies are planned? (2:58)
4. How have these findings changed the role of continuous glucose monitoring (CGM) and insulin delivery in the management of type 1 diabetes? (3:44)
5. What barriers exist to the wider utilisation of CGM and how may they be overcome? (4:16)
Jan Soupal has no conflicts of interest to declare in relation to this video.
Filmed at the Annual Meeting of the European Association of the Study of Diabetes (EASD) Barcelona, Spain 2019.
